Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical util
BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 22, 2025 /PRNewswire/ -- Menarini Silicon Biosystems, a pioneer of cell-based liquid biopsy technology, ann ...
About You You are a confident and capable clinical leader with a passion for oncology and haematology nursing. You will bring: Demonstrated leadership experience in Oncology / Haematology or at Nurse ...
The Prosthetics and Orthotics Department at St Vincent’s Hospital Melbourne (SVHM) has an exciting opportunity for a motivated dual-practicing clinician to develop their acute patient management ...
There's no place like home for Christmas, and for some families that wish has been granted, with their children spending the festive season at home.
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Res
MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
For more information, please apply or contact Kiran Kalasipakam on 07 5621 0077 or email on Contact Email: [email protected] General Registration with AHPRA and current work rights in ...
MEDIPOST Announces the Exclusive Commercialization License Agreement with Teikoku Seiyaku for Knee O
South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM® targeting the Japanese knee osteoarthritis market. SEOUL, South ...
A ban on puberty blockers for children has been imposed in a second Australian jurisdiction to protect kids from ...
Gene Solutions Concludes Successful ESMO Asia Congress 2025 with AI-Powered Multi-Omics Liquid Biops
Gene Solutions, a pioneering genetic testing company, announced key achievements at the European Society for Medic ...
A dengue fever alert system on trial in Vietnam will help protect locals from the virus as well as Australians heading to the popular tourist destination.
Rona Therapeutics Unveils the Global First Bi-valent PCSK9-LPA siRNA into Clinical Development for C
SHANGHAI and SANTA BARBARA, Calif., Dec. 17, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in next-generation RNAi medicines, today announced the ...
Concerned about rates of chronic diseases, Indigenous communities and researchers have worked together to develop a lower sugar alternative to soft drink.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results